Arche Investment
Seoularche-inv.com
Overview
Arche Investment is a Seoul-based corporate venture capital firm and subsidiary of Reyon Pharmaceutical that focuses on early-stage investments in the biotechnology and pharmaceutical sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Neuracle Science | May 2024 | Private Placement | Co-investor |
| Cerecin | Oct 2021 | Series B | Lead |
| Neuracle Science | Jun 2019 | Series C | Co-investor |
| Neuracle Science | Aug 2018 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
